Global Pain Management Market - Segmented by Type, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)

SKU ID :INH-12347856 | Published Date: 21-May-2018 | No. of pages: 108
1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porter's Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitute Product and Services 5.2.5 Competitive Rivalry Within the Industry 6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 6.1 Market Drivers 6.1.1 Growing Demand for Long-term Pain Management Among the Geriatric Population 6.1.2 High Proven Efficacy of Pain Management Devices for the Treatment of Chronic Pain 6.1.3 Rise in Acute and Chronic Pain as a Result af Chronic Health Conditions 6.1.4 Development of Novel Pain Management Devices 6.2 Market Restraints 6.2.1 Low Awareness about the Availability and Use of Pain Management Devices 6.2.2 Shortage of Pain Specialists and Low Number of Pain Clinics in Several Countries 6.2.3 High Procedural and Purchase Cost of Pain Management Devices 6.3 Opportunities 6.4 Key Challenges 7. Market Segmentation 7.1 By Type 7.1.1 Neurostimulation Devices 7.1.1.1 Transcutaneous Electrical Nerve Stimulation (TENS) Devices 7.1.1.2 Spinal Cord Stimulation (SCS) Devices 7.1.2 Analgesic Infusion Pumps 7.1.2.1 Intrathecal Infusion Pumps 7.1.2.2 External Infusion Pumps 7.2 By Application 7.2.1 Neuropathic Pain 7.2.2 Cancer Pain 7.2.3 Facial Pain & Migraine 7.2.4 Musculoskeletal Pain 7.2.5 Others 7.3 By Geography 7.3.1 North America 7.3.1.1 United States 7.3.1.2 Canada 7.3.1.3 Mexico 7.3.2 Europe 7.3.2.1 France 7.3.2.2 Germany 7.3.2.3 United Kingdom 7.3.2.4 Italy 7.3.2.5 Spain 7.3.2.6 Rest of Europe 7.4.3 Asia-Pacific 7.4.3.1 China 7.4.3.2 Japan 7.4.3.3 India 7.4.3.4 Australia 7.4.3.5 South Korea 7.4.3.6 Rest of Asia-Pacific 7.4.4 Middle East & Africa 7.4.4.1 GCC 7.4.4.2 South Africa 7.4.4.3 Rest of Middle East & Africa 7.4.5 South America 7.4.5.1 Brazil 7.4.5.2 Argentina 7.4.5.3 Rest of South America 8. Competitive Landscape 8.1 Mergers & Acquisition Analysis 8.2 Agreements, Collaborations, and Partnerships 8.3 New Products Launches 9. Key Players 9.1 Becton, Dickinson and Company 9.2 Boston Scientific Corporation 9.3 Braun Melsungen AG 9.4 Halyard Health, Inc. 9.5 Hospira, Inc. (A Subsidiary of Pfizer Inc.) 9.6 Medtronic PLC 9.7 Neurotech Na, Inc. (A Subsidiary of Theragen LLC) 9.8 Nevro Corp. 9.9 Smiths Medical 9.10 ST. Jude Medical, Inc. *List Not Exhaustive 10. Future of the Market
Becton, Dickinson and Company, Boston Scientific Corporation, Braun Melsungen AG, Halyard Health, Inc., Hospira, Inc. (a Subsidiary of Pfizer Inc.), Medtronic PLC , Neurotech Na, Inc. (A Subsidiary of Theragen LLC), Nevro Corp., Smiths Medical, and ST. Jude Medical, Inc.
  • PRICE
  • $4250
    $8750

Our Clients